RankingsPricing
  1. US-listed companies
  2. ACADIA PHARMACEUTICALS INC
  3. Financials
  4. Return on Assets

ACADIA PHARMACEUTICALS INC【ACAD】

Market cap
$4.5B
P/E ratio
SummaryFinancials
Period EndReturn on Assets (Million USD)YoY (%)
Dec 31, 202423.4-355.07%
Dec 31, 2023-9.2-72.66%
Dec 31, 2022-33.5+48.14%
Dec 31, 2021-22.6-37.06%
Dec 31, 2020-36+1.18%
Dec 31, 2019-35.5-32.96%
Dec 31, 2018-53-13.36%
Dec 31, 2017-61.2-11.70%
Dec 31, 2016-69.3+15.36%
Dec 31, 2015-60.1+67.20%
Dec 31, 2014-35.9+41.00%
Dec 31, 2013-25.5-14.00%
Dec 31, 2012-29.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)